Prognostic and Predictive Value of the 21-Gene Recurrence Score Assay in a Randomized Trial of Chemotherapy for Postmenopausal, Node-Positive, Estrogen Receptor-Positive Breast Cancer

BACKGROUND: The 21-gene Recurrence Score assay (RS) is prognostic for women with node-negative, estrogen receptor (ER)-positive breast cancer (BC) treated with tamoxifen. A low RS predicts little benefit of chemotherapy. For node-positive BC, we investigated whether RS was prognostic in women treate...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Albain, Kathy S., Barlow, William E., Shak, Steven, Hortobagyi, Gabriel N., Livingston, Robert B., Yeh, I-Tien, Ravdin, Peter, Bugarini, Roberto, Baehner, Frederick L., Davidson, Nancy E., Sledge, George W., Winer, Eric P., Hudis, Clifford, Ingle, James N., Perez, Edith A., Pritchard, Kathleen I., Shepherd, Lois, Gralow, Julie R., Yoshizawa, Carl, Allred, D. Craig, Osborne, C. Kent, Hayes, Daniel F.
Format: Artigo
Jezik:Inglês
Izdano: 2009
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3058239/
https://ncbi.nlm.nih.gov/pubmed/20005174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(09)70314-6
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki